[(1S,4R,7S,9R,13R)-16-Hydroxy-11-(hydroxymethyl)-4,8,8,15-tetramethyl-12-oxo-3-oxatetracyclo[11.3.0.02,4.07,9]hexadec-10-en-13-yl] 3 -phenylprop-2-enoate
CAS: 62820-11-5
Rif. 3D-MCA82011
| 10mg | Prezzo su richiesta | ||
| 25mg | Prezzo su richiesta | ||
| 50mg | Prezzo su richiesta |
Informazioni sul prodotto
- 2-Propenoic acid, 3-phenyl-, (1aS,1bR,2S,3S,4aR,6E,7aR,8aS,10aR)-1a,1b,2,3,4,5,7a,8,8a,9,10,10a-dodecahydro-2-hydroxy-6-(hydroxymethyl)-3,8,8,10a-tetramethyl-5-oxo-4aH-cyclopenta[3,4]cyclopropa[8,9]cycloundec[1,2-b]oxiren-4a-yl ester, (2E)-
- 2-Propenoic acid, 3-phenyl-, 1a,1b,2,3,4,5,7a,8,8a,9,10,10a-dodecahydro-2-hydroxy-6-(hydroxymethyl)-3,8,8,10a-tetramethyl-5-oxo-4aH-cyclopenta[3,4]cyclopropa[8,9]cycloundec[1,2-b]oxiren-4a-yl ester, [1aS-[1aR*,1bS*,2R*,3R*,4aS*(E),6E,7aS*,8aR*,10aS*]]-
- Jolkinol A
- 4aH-Cyclopenta[3,4]cyclopropa[8,9]cycloundec[1,2-b]oxirene, 2-propenoic acid deriv.
(1S,4R,7S,9R,13R)-16-Hydroxy-11-(hydroxymethyl)-4,8,8,15-tetramethyl-12-oxo-3-oxatetracyclo[11.3.0.02,4.07,9]hexadec-10-en-13-yl] 3 -phenylprop-2-enoate is a skeleton that contains a mixture of daphnine and lathyris diterpenes. It has been shown to have antitumour activity in both rodent models and in human cancer cells. The biological properties of this compound are being investigated further. This compound is known to be an inhibitor of translation and transcription by binding to the ribosome and inhibiting protein synthesis at the translational level. [(1S,4R,7S,9R,13R)-16-Hydroxy-11-(hydroxymethyl
Proprietà chimiche
Richiesta tecnica su: 3D-MCA82011 [(1S,4R,7S,9R,13R)-16-Hydroxy-11-(hydroxymethyl)-4,8,8,15-tetramethyl-12-oxo-3-oxatetracyclo[11.3.0.02,4.07,9]hexadec-10-en-13-yl] 3 -phenylprop-2-enoate
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
